Skip to main content
logo
Bambusa Therapeutics, Inc. (BBTX)
Bambusa Therapeutics will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Bambusa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Year Ending
TTMDec '25 Dec '24
Net Income
-48.7-39.33-
Share-Based Compensation
-5.380.19
Other Operating Activities
7.8-4.098.91
Operating Cash Flow
-40.9-39.8-4.63
Operating Cash Flow Growth
---

Investing Activities

Year Ending
TTMDec '25 Dec '24
Change in Investments
--39.73-
Investing Cash Flow
-24.7-39.73-

Financing Activities

Year Ending
TTMDec '25 Dec '24
Share Issuance / Repurchase
-120.8114
Financing Cash Flow
33.02120.8114

Net Cash Flow

Year Ending
TTMDec '25 Dec '24
Net Cash Flow
-32.5841.289.36

Free Cash Flow

Year Ending
TTMDec '25 Dec '24
Free Cash Flow
-40.9-39.8-4.63
Free Cash Flow Growth
---